Abstract
To develop a treatment strategy for peritoneal carcinomatosis using a combination of extended peritoneal resections, local destructive procedures and hyperthermic intraperitoneal chemotherapy creates great concern between healthcare workers involved in these procedures. New professional risks exist: risk of exposure to cytotoxic drugs, environmental risks (inhalation of smoke, aerosolization of chemotherapy agents). Information, education and training of healthcare workers is mandatory in order to ensure proper evaluation, prevention, and management of professional exposure risks in coordination with the occupational health office.
MeSH terms
-
Air Pollutants, Occupational / toxicity
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Camptothecin / administration & dosage
-
Camptothecin / adverse effects
-
Camptothecin / analogs & derivatives
-
Carcinoma / drug therapy*
-
Carcinoma / surgery
-
Chemotherapy, Cancer, Regional Perfusion / adverse effects*
-
Chemotherapy, Cancer, Regional Perfusion / education
-
Chemotherapy, Cancer, Regional Perfusion / methods
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Decontamination / methods
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Drug Compounding / adverse effects
-
Electrosurgery / adverse effects
-
Hot Temperature*
-
Humans
-
Irinotecan
-
Mitomycin / administration & dosage
-
Mitomycin / adverse effects
-
Occupational Exposure / adverse effects
-
Occupational Exposure / prevention & control*
-
Operating Rooms
-
Organoplatinum Compounds / administration & dosage
-
Organoplatinum Compounds / adverse effects
-
Peritoneal Neoplasms / drug therapy*
-
Peritoneal Neoplasms / surgery
-
Protective Clothing
-
Pyridines / administration & dosage
-
Pyridines / adverse effects
-
Smoke / adverse effects
-
Ventilation / methods
Substances
-
Air Pollutants, Occupational
-
Antineoplastic Agents
-
Organoplatinum Compounds
-
Pyridines
-
Smoke
-
oxiplatin
-
Mitomycin
-
Irinotecan
-
Doxorubicin
-
Cisplatin
-
Camptothecin